Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
86 participants
INTERVENTIONAL
2025-12-15
2029-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main hypothesis of the study is that knowledge acquired during everyday life contributes to the subsequent allocation of processing resources, via engagement of the DAN/VAN attention systems.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tracking Information Flow in the Brain
NCT04175119
Attentional Control
NCT03872999
Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings
NCT06883981
Magnetoencephalography (MEG), Attention and Conscience
NCT01592175
Brain Correlates of Visual Processing of Emotional Scenes in ACTion and EMOtional Judgments During Normal VIeillissement
NCT03969043
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Old vs new objects
The following week after the "Old vs new objects" encoding phase of 3 weeks, participants will have an fMRI.
During fMRI, participants will see objects already seen or not seen during the encoding phase.
Old vs new objects" encoding phase and fMRI
During the encoding phase, a set of 60 objects will be presented to the participants in their everyday life. Pictures of objects sent to their app mobile phone over a period of 3 weeks.
The following week, participants will have an fMRI. During fMRI, participants will see objects already seen or not seen during the encoding phase.
incongruent vs. congruent contexts
The following week after the "incongruent vs. congruent contexts" encoding phase of 3 weeks, participants will have an fMRI.
During fMRI, participants will see objects encoding in congruent or incongruent contexts.
" incongruent vs. congruent contexts " encoding phase and fMRI
During the encoding phase, a set of 60 objects will be presented to the participants in their everyday life. Pictures of objects sent to their app mobile phone over a period of 3 weeks. This time, the objects will be chosen according to the participant's location.
The following week, participants will have an fMRI. During fMRI, participants will see objects encoding in congruent/incongruent contexts.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Old vs new objects" encoding phase and fMRI
During the encoding phase, a set of 60 objects will be presented to the participants in their everyday life. Pictures of objects sent to their app mobile phone over a period of 3 weeks.
The following week, participants will have an fMRI. During fMRI, participants will see objects already seen or not seen during the encoding phase.
" incongruent vs. congruent contexts " encoding phase and fMRI
During the encoding phase, a set of 60 objects will be presented to the participants in their everyday life. Pictures of objects sent to their app mobile phone over a period of 3 weeks. This time, the objects will be chosen according to the participant's location.
The following week, participants will have an fMRI. During fMRI, participants will see objects encoding in congruent/incongruent contexts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be right-handed
* Do not wear glasses
* Have a mobile-phone compatible with the application, minimum 6rd generation Android operating system, with geo-localization activated and accepted by the user
* Undertake to comply with the instructions and recommendations for MRI examination
* Provide informed written consent to participate in the study
Exclusion Criteria
* Cognitive problems limiting the understanding of instructions
* Recent taking psychotropic drugs (antidepressants, anxiolytics, antipsychotics). The main treatments not authorized during this research are the following: Psychotropic treatments (drugs that can induce changes in perception, sensation, mood, consciousness or behavior). Like what:
* Antipsychotics (valproic acid, amisulpride, aripiprazole, clozapine, cyamemazin, haloperidol, loxapine, olanzapine, risperidone).
* Antidepressants (Amitriptyline, Citalopram, Clomipramine, Duloxetine, Escitalopam, Fluoxetine, Mianserine, Mirtazapine, Nortriptyline, Paroxetine, Sertraline, Venlafaxine).
* Anxyolitics
* Pregnant or breastfeeding women
* Persons deprived of their liberty by a judicial or administrative decision
* Persons admitted to a health or social institution for purposes other than research
* Adults subject to a legal protection measure (guardianship, curatorship)
* Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
* Participation in another research study of the current study
* Contraindication for fMRI scanning
* Participant not agreeing to be informed in the event of the incidental discovery of an anomaly on MRI
• For visit number 2 :
* Alcohol consumption (\> 3 drinks) in the 24h before the experiment
* Alcohol consumption the day of the experiment
* Cafeine consumption 1 hour or less before the experiment
* Drug consumption within the 24h preceding the experiment
* Antimalarial treatment within the 3 days preceding the experiment
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCBL1, CRNL Inserm U1028, CNRS UMR5292, équipe IMPACT
Bron, Rhone, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL25_0108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.